News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Curley Joanne
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/23/2023 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Sold 1,490 shares
@ $16.6558, valued at
$24.8k
|
|
12/19/2022 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Sold 1,429 shares
@ $19.1204, valued at
$27.3k
Sold 783 shares
@ $20.1697, valued at
$15.8k
Exercised 2,212 options to buy
@ $2.8968, valued at
$6.4k
|
|
12/14/2022 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Sold 6,900 shares
@ $18.2498, valued at
$125.9k
Sold 11,733 shares
@ $18.2767, valued at
$214.4k
Sold 1,078 shares
@ $18.19, valued at
$19.6k
Exercised 6,900 options to buy
@ $11, valued at
$75.9k
Exercised 11,733 options to buy
@ $11, valued at
$129.1k
Exercised 1,078 options to buy
@ $6.3728, valued at
$6.9k
|
|
12/08/2022 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Sold 494 shares
@ $16.47, valued at
$8.1k
|
|
11/21/2022 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Sold 1,078 shares
@ $15.8606, valued at
$17.1k
Sold 2,211 shares
@ $15.8436, valued at
$35k
Exercised 1,078 options to buy
@ $6.3728, valued at
$6.9k
Exercised 2,211 options to buy
@ $2.8968, valued at
$6.4k
|
|
10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/06/2022 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Sold 988 shares
@ $21.64, valued at
$21.4k
|
|
09/22/2022 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Sold 978 shares
@ $20.5442, valued at
$20.1k
Sold 100 shares
@ $21, valued at
$2.1k
Sold 1,828 shares
@ $20.4757, valued at
$37.4k
Sold 334 shares
@ $20.9153, valued at
$7k
Sold 2,314 shares
@ $20.241, valued at
$46.8k
Sold 10,112 shares
@ $20.8045, valued at
$210.4k
Sold 910 shares
@ $21.1255, valued at
$19.2k
Sold 264 shares
@ $22.3465, valued at
$5.9k
Exercised 1,078 options to buy
@ $6.3728, valued at
$6.9k
Exercised 2,162 options to buy
@ $2.8968, valued at
$6.3k
Exercised 12,426 options to buy
@ $11, valued at
$136.7k
|
|
09/08/2022 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Sold 988 shares
@ $18.63, valued at
$18.4k
|
|
08/23/2022 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Granted 12,500 shares
@ $0 Sold 378 shares
@ $18.8854, valued at
$7.1k
Sold 700 shares
@ $19.7607, valued at
$13.8k
Sold 710 shares
@ $18.9312, valued at
$13.4k
Sold 1,451 shares
@ $19.8685, valued at
$28.8k
Sold 2,766 shares
@ $18.6114, valued at
$51.5k
Sold 904 shares
@ $19.8055, valued at
$17.9k
Sold 1,030 shares
@ $18.4241, valued at
$19k
Sold 600 shares
@ $19.6457, valued at
$11.8k
Exercised 1,078 options to buy
@ $6.3728, valued at
$6.9k
Exercised 2,161 options to buy
@ $2.8968, valued at
$6.3k
|
|
08/04/2022 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Sold 988 shares
@ $16.81, valued at
$16.6k
|
|
07/20/2022 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Sold 5,384 shares
@ $16.0158, valued at
$86.2k
Sold 6 shares
@ $16.55, valued at
$99.3 Sold 6,046 shares
@ $16.0123, valued at
$96.8k
Sold 8 shares
@ $16.545, valued at
$132.4 Exercised 5,390 options to buy
@ $6.3728, valued at
$34.3k
Exercised 6,054 options to buy
@ $2.8968, valued at
$17.5k
|
|
07/15/2022 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Sold 6,354 shares
@ $15.1297, valued at
$96.1k
Sold 2,750 shares
@ $15.1744, valued at
$41.7k
Exercised 6,354 options to buy
@ $2.8968, valued at
$18.4k
|
|
07/11/2022 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Sold 3,487 shares
@ $15.0332, valued at
$52.4k
Sold 3,514 shares
@ $15.0764, valued at
$53k
Sold 2,665 shares
@ $15.0297, valued at
$40.1k
Exercised 3,487 options to buy
@ $6.3728, valued at
$22.2k
Exercised 3,514 options to buy
@ $2.8968, valued at
$10.2k
|
|
06/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/18/2022 |
4
| Curley Joanne (Chief Development Officer) has filed a Form 4 on Vera Therapeutics, Inc.
Txns:
| Granted 52,964 options to buy
@ $20.94, valued at
$1.1M
|
|
05/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/13/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
04/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/27/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|